IP Library Granted Patent US 10,191,038
Granted Patent B2
US 10,191,038 · App. 14/007,412 · Granted Jan 29, 2019

Immunological measuring method and measuring kit for whole blood sample

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,191,038
App. No.
14/007,412
Granted
Jan 29, 2019
Kind
B2
Abstract

In a known method of measuring a target substance, comprising: providing a sample solution containing the target substance, a first reaction solution, and a second reaction solution; sequentially aspirating the sample solution and the first reaction solution, using a measuring apparatus equipped with a dispensing unit, into the dispensing unit; discharging them at a time from the dispensing unit, to bring them into contact with the second reaction solution, and to form a complex of the target substance and a first partner which is contained in at least one of the first reaction solution or the second reaction solution and reacts specifically with the target substance; and analyzing the resulting complex, an improved method capable of inhibiting a reaction which adversely affects measurement results is provided. In this improved method, the specific gravity of the sample solution is different from the specific gravity of the first reaction solution; and the sample solution and the first reaction solution are aspirated into the dispensing unit in an overlaid state.

Claims (19)

1. A method of measuring a target substance, comprising:

providing a sample suspected of containing the target substance, or a solution derived from the sample, a first reaction solution, and a second reaction solution;

aspirating the sample or the solution derived therefrom, and the first reaction solution, using a measuring apparatus equipped with a dispensing unit, sequentially in this order into the dispensing unit;

discharging the sample or the solution derived therefrom, and the first reaction solution at the same time from the dispensing unit, to bring the sample or the solution derived therefrom, and the first reaction solution into contact with the second reaction solution, and to form a complex of the target substance, a first partner which is contained in the first reaction solution and reacts specifically with the target substance, and a second partner which is contained in the second reaction solution and reacts specifically with the target substance; and

analyzing the complex, or a signal derived from the complex, wherein

the specific gravity of the first reaction solution is higher than the specific gravity of the sample or the solution derived therefrom;

the sample or the solution derived therefrom and the first reaction solution are aspirated into the dispensing unit in an overlaid state; and

the first partner, which is contained in the first reaction solution and reacts specifically with the target substance, is labeled with a labeling substance, and the second partner, which is contained in the second reaction solution and reacts specifically with the target substance, is immobilized on a solid-phase carrier selected from the group consisting of beads, magnetic particles, and latex particles.

2. The method according to claim 1 , wherein the sample is whole blood.

3. The method according to claim 1 , wherein the first partner which reacts specifically with the target substance is an antibody or an antigen.

4. The method according to claim 1 , wherein the first partner which reacts specifically with the target substance is contained in the first reaction solution, and a second partner which recognizes a region different from a region recognized by the first partner and reacts specifically with the target substance is contained in the second reaction solution.

5. The method according to claim 1 , wherein the dispensing unit is a tip.

6. The method according to claim 1 , wherein the first reaction solution contains at least one substance selected from the group consisting of polyhydric alcohols, sugar alcohols, and sugars.

7. The method according to claim 6 , wherein the first reaction solution contains at least one substance selected from the group consisting of ethylene glycol, propylene glycol, diethylene glycol, glycerol, pentose, hexose, triose, tetrose, heptose, sucrose, trehalose, isotrehalose, kojibiose, sophorose, nigerose, laminaribiose, maltose, cellobiose, isomaltose, gentiobiose, lactose, turanose, maltulose, palatinose, gentiobiulose, mannobiose, melibiose, melibiulose, neolactose, galactosucrose, scillabiose, rutinose, rutinulose, xylobiose, primellose, oligosaccharides, raffinose, melezitose, and maltotriose.

8. The method according to claim 6 , wherein one or more substances described in claim 6 are included in the first reaction solution in an amount of 10% to 30% as the total amount thereof.

9. The method according to claim 1 , wherein at least one of the first reaction solution or the second reaction solution contains a third partner which inhibits the formation of the complex with the target substance and reacts specifically with the target substance.

10. The method according to claim 9 , wherein the third partner which reacts specifically with the target substance is an antibody or an antigen.

11. The method according to claim 9 , wherein the first reaction solution and the second reaction solution contain the third partner which reacts specifically with the target substance.

12. The method according to claim 11 , wherein the third partner which reacts specifically with the target substance is an antibody or an antigen.

Assignments (4)
CHANGE OF ADDRESS Recorded Feb 25, 2024
From: LSI MEDIENCE CORPORATION
To: LSI MEDIENCE CORPORATION
Reel/Frame 066674/0958 →
COMPANY SPLIT Recorded Feb 25, 2024
From: LSI MEDIENCE CORPORATION
To: PHC CORPORATION
Reel/Frame 066675/0001 →
CHANGE OF NAME Recorded Feb 5, 2015
From: MITSUBISHI CHEMICAL MEDIENCE CORPORATION
To: LSI MEDIENCE CORPORATION
Reel/Frame 034916/0083 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2013
From: SHOJI, KEIICHI; YOKOI, HIROYUKI
To: MITSUBISHI CHEMICAL MEDIENCE CORPORATION
Reel/Frame 031276/0985 →